All Releases
Subscribe
Subscribe to Marinomed Biotech AG

18.10.2019 – 17:00

Marinomed Biotech AG

EANS-Voting Rights: Marinomed Biotech AG
Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc with the aim of a
  Europe-wide distribution. The issuer is responsible for the content of this
  announcement.
--------------------------------------------------------------------------------


Overview
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Acquisition or disposal of voting rights
3. Person subject to notification obligation
Name: Erste Asset Management GmbH
City: Wien
Country: Österreich
4. Name of shareholder(s): Erste Asset Management GmbH
5. Date on which the threshold was crossed or reached: 18.10.2019
6. Total positions

 ______________________________________________________________________________
|               |  % of voting  |  % of voting  |              |               |
|               |rights attached|rights through |Total of both |Total number of|
|               |to shares (7.A)|financial/other| in % (7.A +  | voting rights |
|               |               | instruments   |     7.B)     |   of issuer   |
|_______________|_______________|(7.B.1_+_7.B.2)|______________|_______________|
|   Resulting   |               |               |              |               |
| situation on  |               |               |              |               |
|  the date on  |               |               |              |               |
|which threshold|    7.71 %     |    0.00 %     |    7.71 %    |   1 469 772   |
| was crossed / |               |               |              |               |
|    reached    |               |               |              |               |
|_______________|_______________|_______________|______________|_______________|
|  Position of  |               |               |              |               |
|   previous    |               |               |              |               |
| notification  |    0.00 %     |    0.00 %     |    0.00 %    |               |
|(if applicable)|               |               |              |               |
|_______________|_______________|_______________|______________|_______________|


Details
7. Notified details of the resulting situation:

 ______________________________________________________________________________
|A: Voting rights attached to shares                                           |
|______________________________________________________________________________|
|             |    Number of voting rights    |       % of voting rights       |
|             |_______________________________|________________________________|
|             |    Direct     |   Indirect    |    Direct     |    Indirect    |
|  ISIN Code  |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG |
|             |     2018)     |     2018)     |     2018)     |     2018)      |
|_____________|_______________|_______________|_______________|________________|
|ATMARINOMED6 |        113 317|               |         7.71 %|                |
|_____________|_______________|_______________|_______________|________________|
| SUBTOTAL A  |            113 317            |             7.71 %             |
|_____________|_______________________________|________________________________|


 ______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG  |
|2018                                                                          |
|______________________________________________________________________________|
|             |               |               |Number of voting |              |
|             |               |               | rights that may |              |
|             |               |               |       be        |              |
|   Type of   |Expiration Date|Exercise Period|acquired if the  | % of voting  |
| instrument  |               |               |  instrument is  |    rights    |
|             |               |               |    exercised    |              |
|_____________|_______________|_______________|_________________|______________|
|             |               | SUBTOTAL B.1  |                 |              |
|_____________|_______________|_______________|_________________|______________|


 _____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018                                                                         |
|_____________________________________________________________________________|
|  Type of  | Expiration | Exercise  | Physical /  | Number of   |% of voting |
|instrument |    Date    |  Period   |    Cash     |voting rights|   rights   |
|___________|____________|___________|_Settlement__|_____________|____________|
|           |            |           |SUBTOTAL B.2 |             |            |
|___________|____________|___________|_____________|_____________|____________|


8. Information in relation to the person subject to the notification obligation:
Person subject to the notification obligation is not controlled by any natural
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuer.

9. In case of proxy voting
Date of general meeting: -
Voting rights after general meeting: - is equivalent to - voting rights.

10. Additional comments:
The voting rights held by Erste Asset Management GmbH as stated in section 8 are
not held directly but by the investment funds managed by the management company.
They are therefore not holdings of the management company.

Note of the Issuer: This is a translation of the received shareholder
notification in German language. The translation into English is not binding.



Further inquiry note:

Dr. Eva Prieschl-Grassauer
Chief Scientific Officer, Marinomed
Veterinärplatz 1, 1210 Vienna, Austria
T +43 (0)1 250 77 4460
E-Mail: eva.prieschl@marinomed.com
http://www.marinomed.com

Roland Mayrl
Managing Partner, Metrum Communications
Bauernmarkt 10/19, 1010 Vienna, Austria
T +43 (0) 1 504 69 87 331
E-Mail: r.mayrl@metrum.at
http://www.metrum.at

end of announcement                         euro adhoc
--------------------------------------------------------------------------------



issuer:       Marinomed Biotech AG
              Veterinärplatz 1
              A-1210 Wien
phone:        0043250774460
FAX:          0043250774493
mail:      office@marinomed.com
WWW:       www.marinomed.com
ISIN:         ATMARINOMED6, AT0000A1WD52
indexes:      
stockmarkets: Wien
language:     English
 

Original content of: Marinomed Biotech AG, transmitted by news aktuell